Cargando…

Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening

The World Health Organization has recommended prevaccination screening for prior dengue infection as the preferred approach prior to vaccination with the dengue vaccine CYD-TDV. These screening tests need to be highly specific and sensitive, and deliverable at the point-of-care. We evaluate here the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liberal, Vasco, Forrat, Remi, Zhang, Cong, Pan, Charles, Bonaparte, Matthew, Yin, Wushan, Zheng, Lingyi, Viscardi, Valeria, Wu, Yukun, Ataman-Önal, Yasemin, Savarino, Stephen, Chen, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241662/ https://www.ncbi.nlm.nih.gov/pubmed/35604130 http://dx.doi.org/10.1128/spectrum.00711-21

Ejemplares similares

Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials
por: DiazGranados, Carlos A, et al.
Publicado: (2021)

CYD Tetravalent Dengue Vaccine Performance by Baseline Immune Profile (Monotypic/Multitypic) in Dengue-Seropositive Individuals
por: DiazGranados, Carlos A, et al.
Publicado: (2020)

Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas
por: Nascimento, Eduardo J. M., et al.
Publicado: (2019)

Serostatus testing and dengue vaccine cost–benefit thresholds
por: Pearson, Carl A. B., et al.
Publicado: (2019)

Risk of dengue virus infection according to serostatus in individuals from dengue endemic areas of Mexico
por: Amaya-Larios, I. Y., et al.
Publicado: (2020)

Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
por: Forrat, Rémi, et al.
Publicado: (2021)

Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants
por: Thulin, Natalie K., et al.
Publicado: (2020)

Dengue IgG Seropositivity and Zika Viral Load
por: Read, Jennifer, et al.
Publicado: (2017)

Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based study
por: Lopez, Anna Lena, et al.
Publicado: (2021)

Zika and Dengue Interactions in the Context of a Large Dengue Vaccine Clinical Trial in Latin America
por: Zambrano, Betzana, et al.
Publicado: (2021)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Seropositivity of SARS-CoV-2 IgG Antibody among People in Dhaka City during the Prevaccination Period
por: Ahmed, Zabed Bin, et al.
Publicado: (2022)

Enhanced performance of an innovative dengue IgG/IgM rapid diagnostic test using an anti-dengue EDI monoclonal antibody and dengue virus antigen
por: Lee, Jihoo, et al.
Publicado: (2015)

Field evaluation of rapid diagnostic tests to determine dengue serostatus in Timor-Leste
por: Arkell, Paul, et al.
Publicado: (2022)

IgG1 and IgG4 antibodies against Aedes aegypti salivary proteins and risk for dengue infections
por: Cardenas, Jenny C., et al.
Publicado: (2019)

Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews
por: Luo, R., et al.
Publicado: (2019)

Evaluation of VIDAS(®) Diagnostic Assay Prototypes Detecting Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM and IgG Antibodies
por: Somlor, Somphavanh, et al.
Publicado: (2021)

IgG Against Dengue Virus in Healthy Blood Donors, Zanzibar, Tanzania
por: Vairo, Francesco, et al.
Publicado: (2014)

Correction to: Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens
por: Andries, Anne-Claire, et al.
Publicado: (2016)

Comparative evaluation of three dengue duo rapid test kits to detect NS1, IgM, and IgG associated with acute dengue in children in Myanmar
por: Jang, Woong Sik, et al.
Publicado: (2019)

Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda
por: Bongomin, Felix, et al.
Publicado: (2022)

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
por: Dayan, Gustavo H, et al.
Publicado: (2014)

Significance of IgG optical density ratios (index value) in single reactive anti-Dengue virus IgG capture ELISA
por: Chatterjee, Shiv Sekhar, et al.
Publicado: (2016)

Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
por: Teo, Andrew, et al.
Publicado: (2023)

Development of ASSURE(®) Dengue IgA Rapid Test for the Detection of Anti-dengue IgA from Dengue Infected Patients
por: Tan, Yun Ying, et al.
Publicado: (2011)

Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood
por: Tran, Thanh Nga T, et al.
Publicado: (2006)

Differentiating secondary from primary dengue using IgG to IgM ratio in early dengue: an observational hospital based clinico-serological study from North India
por: Changal, Khalid Hamid, et al.
Publicado: (2016)

Reliable Classifier to Differentiate Primary and Secondary Acute Dengue Infection Based on IgG ELISA
por: Cordeiro, Marli Tenório, et al.
Publicado: (2009)

Corrigendum to “Seroprevalence of Dengue IgG Antibodies among Healthy Adult Population in Lahore, Pakistan”
por: Mahmood, Shahid, et al.
Publicado: (2017)

Kinetics of IgG Antibodies in Previous Cases of Dengue Fever—A Longitudinal Serological Survey
por: Wu, Qilin, et al.
Publicado: (2020)

Correction: Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
por: Teo, Andrew, et al.
Publicado: (2023)

Kinetics of non-structural protein 1, IgM and IgG antibodies in dengue type 1 primary infection
por: Hu, Dongmei, et al.
Publicado: (2011)

Performance of VIDAS(®) Diagnostic Tests for the Automated Detection of Dengue Virus NS1 Antigen and of Anti-Dengue Virus IgM and IgG Antibodies: A Multicentre, International Study
por: Versiani, Alice F., et al.
Publicado: (2023)

Comparative genomics of prevaccination and modern Bordetella pertussis strains
por: Bart, Marieke J, et al.
Publicado: (2010)

Serostatus of IgG antibody against mumps virus in adult population of Al Madinah Al Munawarah, Saudi Arabia
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation
por: Bae, Hyunjoo, et al.
Publicado: (2023)

Dengue Virus Activates Polyreactive, Natural IgG B Cells after Primary and Secondary Infection
por: Balakrishnan, Thavamalar, et al.
Publicado: (2011)

Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virus
por: Pitaksajjakul, Pannamthip, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_27443l5k56p2v3ddd9lic3596j